Search - tctmd.com

Displaying 321 - 340 of 423

Sort: Relevancy | Date

Presentation TCT 2014

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

Presentation

The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis

Presenter: G. Christopoulos

July 14, 2014

Presentation Fellows 2014

Stent Thrombosis and Restenosis

Presenter: Ajay Kirtane

April 13, 2014

Presentation PCI Outcomes 2014

The Thoughtful Approach to Recurrent DES Restenosis

Presenter: Robert A. Byrne

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Presenter: Soo-Jin Kang

March 27, 2014

Presentation CIT 2014

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

Presenter: M Bedossa

March 22, 2014

Presentation CIT 2014

Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!

Presenter: Patrick W. Serruys

March 20, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

Presentation

Immediate Results and Long-term Clinical Outcome of Patients with Unprotected Distal LM Restenosis

Presenter: Soledad Ojeda

January 20, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Lisette Okkels Jensen

October 30, 2013

Presentation TCT 2013

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

Presenter: Yasuhiro Honda

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

Case Presentation 1: A Long-Run Restenosis Tale

Presenter: Marin Postu

October 29, 2013

Presentation TCT 2013

Restenosis and Stent Thrombosis

Presenter: Kevin Croce

October 28, 2013

Presentation TCT 2013

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Presenter: John Ormiston

October 28, 2013

Advertisement

Case #1: Restenosis in an Unusual Venous Bypass Bifurcated Lesion

The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis

Stent Thrombosis and Restenosis

The Thoughtful Approach to Recurrent DES Restenosis

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!

Left Main Restenosis: Incidence, Implications, and Management

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Immediate Results and Long-term Clinical Outcome of Patients with Unprotected Distal LM Restenosis

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Case Presentation 1: A Long-Run Restenosis Tale

Restenosis and Stent Thrombosis

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content